Subjects: Cost Control -- legislation & jurisprudence - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Cost Control -- legislation & jurisprudence

1. Cost savings

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):: Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
United States

2. CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act

Author(s):: Adams, Christopher, author
Herrnstadt, Evan, author
Publication:: [Washington, DC] : Congressional Budget Office, February 2021
Subject(s):: Cost Control -- legislation & jurisprudence
Drug Costs -- legislation & jurisprudence
Models, Economic
Negotiating
United States

3. State specific responses

Author(s):: Berry, Melissa D., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
Subject(s):: COVID-19 -- epidemiology
Delivery of Health Care -- legislation & jurisprudence
Healthcare Disparities -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
State Government
Cost Control -- legislation & jurisprudence
Insurance Coverage -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
United States

4. Deficit Reduction Act of 2005: implications for Medicaid

Publication:: Washington, D.C. : Kaiser Commission on Medicaid and the Uninsured, February 2006
Subject(s):: Cost Control -- legislation & jurisprudence
Medicaid -- legislation & jurisprudence
United States

5. Medicare Part B drug payments: impact of price substitutions based on 2018 average sales prices

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2020
Subject(s):: Cost Control -- legislation & jurisprudence
Drug Substitution -- economics
Government Regulation
Medicare Part B -- economics
United States
United States. Department of Health and Human Services

6. Medicare Part B: payments and use for selected new, high-cost drugs : report to Congressional Committees

Publication:: Washington, DC : United States Government Accountability Office, March 2021
Subject(s):: Cost Control -- legislation & jurisprudence
Government Regulation
Legislation, Drug -- economics
Medicare Part B -- economics
United States